{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T03:54:01Z","timestamp":1754020441257},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/rlu.0000000000001606","type":"journal-article","created":{"date-parts":[[2017,2,18]],"date-time":"2017-02-18T18:17:08Z","timestamp":1487441828000},"page":"e269-e272","source":"Crossref","is-referenced-by-count":2,"title":["Brain Perfusion Before and After Surgical Treatment of Moyamoya Disease"],"prefix":"10.1097","volume":"42","author":[{"given":"Cl\u00e9ment","family":"Drouet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Thines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9mence","family":"Porot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Boulahdour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-39-20210204","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol"},{"key":"R2-39-20210204","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1046\/j.1440-1789.2000.00300.x","article-title":"Moyamoya disease","volume":"20","author":"Fukui","year":"2000","journal-title":"Neuropathology"},{"key":"R3-39-20210204","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00259-009-1266-y","article-title":"EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2","volume":"36","author":"Kapucu","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-39-20210204","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuchi.2014.03.004","article-title":"Microsurgical neurovascular anastomosis: the example of superficial temporal artery to middle cerebral artery bypass. Technical principles","volume":"60","author":"Thines","year":"2014","journal-title":"Neurochirurgie"},{"key":"R5-39-20210204","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/01.STR.21.9.1306","article-title":"A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide","volume":"21","author":"Piepgras","year":"1990","journal-title":"Stroke"},{"key":"R6-39-20210204","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1148\/radiol.2016152305","article-title":"Implications of off-label use of acetazolamide in the management of moyamoya disease in Japan","volume":"279","author":"Mugikura","year":"2016","journal-title":"Radiology"},{"key":"R7-39-20210204","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2176\/nmc.50.824","article-title":"Moyamoya disease: recent progress and outlook","volume":"50","author":"Takahashi","year":"2010","journal-title":"Neurol Med Chir (Tokyo"},{"key":"R8-39-20210204","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0303-8467(97)00042-5","article-title":"Moyamoya disease in Europe, past and present status","volume":"99","author":"Yonekawa","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"R9-39-20210204","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.513408","article-title":"Moyamoya disease in Europeans","volume":"39","author":"Kraemer","year":"2008","journal-title":"Stroke"},{"key":"R10-39-20210204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5853\/jos.2015.01739","article-title":"Moyamoya disease: treatment and outcomes","volume":"18","author":"Kim","year":"2016","journal-title":"J Stroke"},{"key":"R11-39-20210204","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.3171\/foc.1998.5.5.8","article-title":"Long-term outcome after STA-MCA anastomosis for moyamoya disease","volume":"5","author":"Miyamoto","year":"1998","journal-title":"Neurosurg Focus"},{"key":"R12-39-20210204","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.surneu.2006.07.017","article-title":"Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery\u2013middle cerebral artery anastomosis in patients with adult-onset moyamoya disease","volume":"67","author":"Fujimura","year":"2007","journal-title":"Surg Neurol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:18:22Z","timestamp":1620973102000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201705000-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001606","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}